Prudential Financial
TGTX icon

Prudential Financial’s TG Therapeutics TGTX Stock Holding History

Prudential Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.25M Buy
168,420
+3,920
+2% +$160K 0.01% 729
2026
Q1 		$5.46M Sell
164,500
-21,110
-11% -$629K 0.01% 890
2025
Q4 		$5.53M Sell
185,610
-9,750
-5% -$318K 0.01% 864
2025
Q3 		$7.06M Buy
195,360
+6,045
+3% +$199K 0.01% 762
2025
Q2 		$6.81M Buy
189,315
+9,925
+6% +$370K 0.01% 771
2025
Q1 		$7.07M Buy
179,390
+10,815
+6% +$364K 0.01% 711
2024
Q4 		$5.07M Sell
168,575
-136,762
-45% -$3.92M 0.01% 871
2024
Q3 		$7.14M Buy
305,337
+219,748
+257% +$4.8M 0.01% 819
2024
Q2 		$1.52M Buy
85,589
+75,035
+711% +$1.2M ﹤0.01% 1580
2024
Q1 		$161K Sell
10,554
-1
-0% -$16 ﹤0.01% 2491
2023
Q4 		$180K Buy
10,555
+330
+3% +$3.83K ﹤0.01% 2457
2023
Q3 		$85.5K Sell
10,225
-45,032
-81% -$628K ﹤0.01% 2455
2023
Q2 		$1.37M Sell
55,257
-88,338
-62% -$2.28M ﹤0.01% 1642
2023
Q1 		$2.16M Buy
+143,595
New +$2.18M ﹤0.01% 1288
2022
Q1 		– Sell
-9,391
Closed -$327K – 2692
2021
Q4 		$327K Sell
9,391
-1,101
-10% -$28.6K ﹤0.01% 2368
2021
Q3 		$328K Sell
10,492
-693
-6% -$21.4K ﹤0.01% 2285
2021
Q2 		$434K Buy
11,185
+310
+3% +$12.2K ﹤0.01% 2181
2021
Q1 		$524K Buy
10,875
+566
+5% +$27.2K ﹤0.01% 2115
2020
Q4 		$536K Buy
10,309
+661
+7% +$22.3K ﹤0.01% 2034
2020
Q3 		$259K Buy
+9,648
New +$222K ﹤0.01% 2214

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Prudential Financial's TGTX Position: Q2 2026 in Review

Prudential Financial increased its TG Therapeutics (TGTX) stake by 2.4% in Q2 2026, buying an estimated $160K and bringing the position to 168,420 shares worth $9.25M. The position accounts for 0.01% of the portfolio, ranked #729.

Prudential Financial first reported a position in TGTX in Q3 2020 and has held it in 20 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Prudential Financial held 168,420 shares of TG Therapeutics worth $9.25M as of Q2 2026.
  • Prudential Financial bought 3,920 TG Therapeutics shares in Q2 2026, an estimated $160K.
  • TG Therapeutics made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #729 holding.
  • Prudential Financial first reported a position in TG Therapeutics in Q3 2020 and has held it in 20 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.